Mollie Leoni
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Mollie Leoni is currently Chief Medical Officer at Kura Oncology, Inc. since 2025.
Formerly, worked as Executive Director-Medical Science at Kyowa Kirin Ltd. from 2018 to 2020 and at Kyowa Kirin Co., Ltd. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KURA ONCOLOGY, INC. 0,21 % | 18/06/2026 | 182.345 ( 0,21 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KURA ONCOLOGY, INC. | Director Técnico/Científico/I+D | 02/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Director Técnico/Científico/I+D | 01/02/2020 |
| KYOWA KIRIN CO., LTD. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.